Site-specific DNA-doxorubicin conjugates display enhanced cytotoxicity to breast cancer cells.
Stuart CH, Horita DA, Thomas MJ, Salsbury FR, Lively MO, Gmeiner WH. Site-specific DNA-doxorubicin conjugates display enhanced cytotoxicity to breast cancer cells. Bioconjug Chem. 2014 Feb 19; 25(2):406-13.